Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
<h4>Background</h4>After admission to hospital, COVID-19 progresses in a substantial proportion of patients to critical disease that requires intensive care unit (ICU) admission.<h4>Methods</h4>In a pragmatic, non-blinded trial, 387 patients aged 40-90 years were randomised t...
Autori principali: | Raja Dhar, John Kirkpatrick, Laura Gilbert, Arjun Khanna, Mahavir Madhavdas Modi, Rakesh K Chawla, Sonia Dalal, Venkata Nagarjuna Maturu, Marcel Stern, Oliver T Keppler, Ratko Djukanovic, Stephan D Gadola |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Public Library of Science (PLoS)
2023-01-01
|
Serie: | PLoS ONE |
Accesso online: | https://doi.org/10.1371/journal.pone.0280745 |
Documenti analoghi
Documenti analoghi
-
ICU Survivors Experience of ICU Diaries: An Ancillary Qualitative Analysis of the ICU Diary Study
di: Cécile Flahault, PhD, et al.
Pubblicazione: (2021-05-01) -
Variation in rates of ICU readmissions and post-ICU in-hospital mortality and their association with ICU discharge practices
di: Nelleke van Sluisveld, et al.
Pubblicazione: (2017-04-01) -
Plasmapheresis in the ICU
di: Guleid Hussein, et al.
Pubblicazione: (2023-12-01) -
The ICU Book
di: Karin Nollain
Pubblicazione: (2008-03-01) -
Biofilms in the ICU
di: Kendra P Rumbaugh
Pubblicazione: (2014-04-01)